Open position!
The Pereira group is seeking for 1 post-doctoral candidate for a collaborative project with the company Asgard therapeutics. The Pereira group has pioneered cell fate reprogramming approaches in immunology with induced dendritic cells (Rosa et al, Science Immunology 2018; Rosa et al, Science Immunology 2022) and has shown recently that the same combination of factors can reprogram tumor cells into
https://www.wcmm.lu.se/article/open-position - 2026-05-29
